跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
NURTEC ODT
Authorized
STANDARD
NURTEC ODT
Pfizer Canada Ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
07b8edc83f2f9d51
Company
Pfizer Canada Ulc
Type
Standard
Approval Details
Approval Id
07b8edc83f2f9d51
Drug Approval Canada Name
NURTEC ODT
Product Name
NURTEC ODT
Status
Marketed
Status Date
2024-03-25
Original Market Date
2024-03-25
Din
02543605
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.12
Atc Original
N02CD06 RIMEGEPANT
Atc Name
n 02 cd 06
Aig Number
0165402001
Company Name
Pfizer Canada Ulc
Company Address
17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path
/organization/pfizer-canada-ulc
Company Information
Pharmaceutical Company Name
Pfizer Canada Ulc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
17300 rte Transcanadienne
Active Ingredients
RIMEGEPANT (RIMEGEPANT SULFATE)
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
07b8edc83f2f9d51
Type
Standard
Back to Health Canada Approvals
NURTEC ODT - Health Canada Drug Approval Details